Importantly, as shown in Figure 2, none of the samples yielded undigested amplicons corresponding to the mutant-type (MT) variant with restriction site deletion, thus confirming that all examined samples retained an intact XhoI site and no loss-of-site mutations were detected in this cohort."The WT LMP-1 XhoIvariant was found in 58 out of 70 NPC tissue samples and absent in 12 out of 70, was examined in relation to histological type and population characteristics, including NPC type, age, gender, race, and CT scan results indicating disease stage at the last patient follow-up. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.